ProQR Therapeutics PRQR
NASDAQ PRQR
$1.26 -0.05 (-3.82%)
At close: Nov 11, 2026 · 4:00 PM EST

ProQR Therapeutics (PRQR) Net Long-Term Debt Issued (Repaid) (2013 - 2022)

Updated

ProQR Therapeutics' Non-Current Debt came in at $4.62 million for the quarter ended Dec 31, 2023, up 6.0% from $4.36 million a year earlier and up 46.7% from the prior quarter.

Analysis

ProQR Therapeutics (PRQR) Net Long-Term Debt Issued (Repaid) (2013 - 2022) Analysis & Trends

As of Dec 31, 2023, ProQR Therapeutics' Non-Current Debt was $4.64 million, up 3.1% from the prior year.

  • Non-Current Debt carries a five-year compound annual growth rate of -16.0% (years ended Dec 2018 to Dec 2023).
  • Going back by year, Non-Current Debt was $4.5 million in the year ended Dec 31, 2022 (-90.3%), $46.53 million in the year ended Dec 31, 2021 (+151.7%), $18.48 million in the year ended Dec 31, 2020 (+29.9%) and $14.23 million in the year ended Dec 31, 2019 (+28.4%).
  • The figure for the quarter ended Dec 31, 2023 represents the highest quarterly Non-Current Debt since the quarter ended Sep 30, 2022.
  • Year-over-year, Non-Current Debt increased in two of the last seven quarters, with an average decline of 39.9%.
  • The fastest year-over-year change in Non-Current Debt over five years came in the quarter ended Jun 30, 2021 (growth of 278.8%), and the weakest in the quarter ended Mar 31, 2021 (a decline of 99.9%).
  • Business Quant data shows PRQR's Non-Current Debt at $3.15 million (quarter ended Sep 30, 2023), $3.89 million (quarter ended Jun 30, 2023) and $4.19 million (quarter ended Mar 31, 2023) in the three quarters before the quarter ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 ProQR Therapeutics 138.02 Mn -322.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 88.50 Mn
Sep 30, 2022 -43.73 Mn
Sep 30, 2021 334,917.60
Jun 30, 2021 685,230.45
Dec 31, 2020 296,880.17
Sep 30, 2020 15.74 Mn
Jun 30, 2020 389,916.89
Mar 31, 2020 320,142.32
Dec 31, 2019 2.24 Mn
Mar 31, 2019 784,273.91
Dec 31, 2018 987,307.91
Sep 30, 2018 133,759.86
Jun 30, 2018 137,246.11
Mar 31, 2018 245,706.56
Dec 31, 2017 588,716.26
Sep 30, 2017 176,259.49
Jun 30, 2017 111,054.48
Dec 31, 2016 191,111.19
Mar 31, 2016 212,881.36
Dec 31, 2015 423,101.27
API Access

ProQR Therapeutics Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=PRQR&period=max&api_key=YOUR_API_KEY